Terms: = Gastric cancer AND NONO, Q15233, 4841, ENSG00000147140, NRB54, P54NRB, NMT55, P54 AND Diagnosis
4 results:
1. Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic cancer Risk From 5 Prospective Cohorts.
Lee AA; Wang QL; Kim J; Babic A; Zhang X; Perez K; Ng K; Nowak J; Rifai N; Sesso HD; Buring JE; Anderson GL; Wactawski-Wende J; Wallace R; Manson JE; Giovannucci EL; Stampfer MJ; Kraft P; Fuchs CS; Yuan C; Wolpin BM
Clin Transl Gastroenterol; 2023 May; 14(5):e00573. PubMed ID: 36854058
[TBL] [Abstract] [Full Text] [Related]
2. LINC00963: A potential cancer diagnostic and therapeutic target.
Xie Z; Zhong C; Shen J; Jia Y; Duan S
Biomed Pharmacother; 2022 Jun; 150():113019. PubMed ID: 35462329
[TBL] [Abstract] [Full Text] [Related]
3. Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and nono.
Yang P; Chen T; Xu Z; Zhu H; Wang J; He Z
Oncotarget; 2016 Jul; 7(27):42183-42194. PubMed ID: 27259250
[TBL] [Abstract] [Full Text] [Related]
4. Serum antibodies positivity to 12 Helicobacter pylori virulence antigens in patients with benign or malignant gastroduodenal diseases--cross-sectional study.
Filipec Kanizaj T; Katicić M; Presecki V; Gasparov S; Colić Cvrlje V; Kolarić B; Mrzljak A
Croat Med J; 2009 Apr; 50(2):124-32. PubMed ID: 19399945
[TBL] [Abstract] [Full Text] [Related]
